My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 130

    1.

    Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy.

    Goldberg I.

    Br J Ophthalmol. 2002 Jun;86(6):691-2. Review. No abstract available. PMID: 12034694 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 1.

    Anton A.

    Br J Ophthalmol. 2002 Jun;86(6):692-3; discussion 695. Review. No abstract available. PMID: 12075596 [PubMed - indexed for MEDLINE]Related articles

    3.

    Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 2.

    Skuta GL.

    Br J Ophthalmol. 2002 Jun;86(6):693-4; discussion 695. Review. No abstract available. PMID: 12075597 [PubMed - indexed for MEDLINE]Related articles

    4.

    Latanoprost : an update of its use in glaucoma and ocular hypertension.

    Perry CM, McGavin JK, Culy CR, Ibbotson T.

    Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

    Pillunat LE, Larsson LI; European and Canadian Latanoprost Study Group.

    Br J Ophthalmol. 2003 Dec;87(12):1492-6.PMID: 14660460 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Beta-blockers in the treatment of chronic simple glaucoma.

    Hitchings RA.

    Br Med J (Clin Res Ed). 1982 Jul 10;285(6335):84-5. No abstract available. PMID: 6123368 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The role of beta blockers in open angle glaucoma.

    Marmion VJ.

    Indian J Ophthalmol. 1982 Jul;30(4):229-31. No abstract available. PMID: 6131867 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertension.

    Quinones R, Earl ML.

    Adv Ther. 2004 Nov-Dec;21(6):370-9.PMID: 15856860 [PubMed - indexed for MEDLINE]Related articles

    9.

    Topical beta-blockers are not associated with an increased risk of treatment for depression.

    Kaiserman I, Kaiserman N, Elhayany A, Vinker S.

    Ophthalmology. 2006 Jul;113(7):1077-80.PMID: 16815397 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)]

    Tugushi OA, Shliapuzhnikova AV, Listopadova NA.

    Vestn Oftalmol. 2005 Jul-Aug;121(4):41-3. Russian. No abstract available. PMID: 16223045 [PubMed - indexed for MEDLINE]Related articles

    11.

    Switching to latanoprost monotherapy for 24 weeks in glaucoma patients.

    Takahashi I, Tanaka M.

    Eur J Ophthalmol. 2004 Sep-Oct;14(5):401-6.PMID: 15506602 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Prospects for neuroprotective glaucoma therapy]

    Grehn F.

    Ophthalmologe. 2001 Oct;98(10):925-8. German. No abstract available. PMID: 11699312 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Treatment of chronic open-angle glaucoma]

    Assouline M, Renard G.

    Rev Prat. 1990 Jun 1;40(16):1497-8. French. No abstract available. PMID: 1972809 [PubMed - indexed for MEDLINE]Related articles

    14.

    An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.

    Stewart WC, Leech J, Sharpe ED, Kulze J, Ellyn J, Day DG.

    Am J Manag Care. 2002 Aug;8(10 Suppl):S240-8.PMID: 12188166 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: a three-year study.

    Gupta V, Srinivasan G, Sharma A, Kapoor KS, Sihota R.

    J Ocul Pharmacol Ther. 2007 Aug;23(4):351-8.PMID: 17803433 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Chronic open-angle glaucoma]

    Béchetoille A, Denis P, Nordmann JP, Sellem E, Valtot F.

    J Fr Ophtalmol. 1997;20(2):166-8. French. No abstract available. PMID: 9099276 [PubMed - indexed for MEDLINE]Related articles

    17.

    Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.

    Zhou Z, Althin R, Sforzolini BS, Dhawan R.

    Br J Ophthalmol. 2004 Nov;88(11):1391-4.PMID: 15489479 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study.

    Diestelhorst M, Schaefer CP, Beusterien KM, Plante KM, Fain JM, Mozaffari E, Dhawan R.

    Eur J Ophthalmol. 2003 Jul;13 Suppl 4:S21-9.PMID: 12948050 [PubMed - indexed for MEDLINE]Related articles

    19.

    Introductory comments on potential differences between beta-blockers in the treatment of open-angle glaucoma.

    Drance SM.

    Surv Ophthalmol. 1999 Jun;43 Suppl 1:S173-5. Review. No abstract available. PMID: 10416760 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.

    Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.

    J Glaucoma. 2008 Apr-May;17(3):233-7.PMID: 18414111 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity